Company Shakeups

Gilead Now #2 in Market Cap

Hat tip to seekingalpha

As far as market cap is concerned, Gilead (GILD) at least
fleetingly topped Amgen (AMGN) as the world’s second highest valued
biotech company. Amgen has taken some hits recently over their anemia
drug franchise and yesterday were overtaken in market capitalization
by a company with a third their revenue.

I made a long Amgen call nearly a year ago… my bad.

Theoretically Related Posts

• October 30, 2008 -- Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round (0)
• October 18, 2008 -- Do Gilead’s Earnings Spell The End of Large Sales Forces? (0)
• July 2, 2008 -- Biopharm Closing Bell: 7.2.08 (0)
• June 30, 2008 -- Biopharm Closing Bell: 6.30.08 (0)
• June 24, 2008 -- Biopharm Closing Bell: 6.24.08 (0)
• June 23, 2008 -- Biopharm Closing Bell: 6.23.08 (0)
• June 12, 2008 -- Biopharm Closing Bell: 6.12.08 (0)
• June 11, 2008 -- Biopharm Closing Bell: 6.11.08 (0)
• June 10, 2008 -- Biopharm Closing Bell: 6.10.08 (0)
• June 10, 2008 -- Biopharm Closing Bell: 6.9.08 (0)

© 2008 Pharmababble.